Gland Pharma has received tentative approval from the United States Food and Drug Administration (USFDA) for Latanoprostene Bunod Ophthalmic Solution, 0.024%.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
Gland Pharma has received tentative approval from the United States Food and Drug Administration (USFDA) for Latanoprostene Bunod Ophthalmic Solution, 0.024%.
| Subscribe To Our Free Newsletter |
